Introduction {#s01}
============

T helper cell (Th)--dependent (TD) antibody production is a critical aspect of the adaptive immune response to pathogens and other foreign antigens ([@bib57]). In vivo TD antibody responses and the critical events of Ig class switching and somatic hypermutation (SHM) are dependent on the formation of germinal centers (GCs), which provide a highly specialized microenvironment for the interaction of T and B cells ([@bib57]; [@bib9]; [@bib59]). Recent studies of GC biology have led to elegant models for the cross talk between follicular helper T cells (Tfh cells) and APCs in the formation of GCs; in the regulated cell trafficking that allows iterative Tfh cell--GC B cell interactions; and ultimately in functional outcomes including affinity maturation, T and B cell memory, negative selection of autoreactive B cells, and Ig class switch recombination ([@bib57]; [@bib9]; [@bib59]). Several studies have visualized the dynamics of T cell--APC interactions in GC responses. Antigen-activated T and B cells first interact at the border of T and B cell zones ([@bib42]; [@bib29]; [@bib30]). However, expression by antigen-activated T cells of Bcl6, an essential transcription factor for Tfh cell differentiation ([@bib25]; [@bib40]; [@bib62]), precedes this T--B cell interaction ([@bib29]; [@bib30]), suggesting that APCs other than B cells, possibly DCs ([@bib44]; [@bib10]; [@bib6]; [@bib17]), are responsible for initiation of the Tfh cell differentiation program. Given the evidence for sequential interaction of T cells with DCs and B cells during the GC response ([@bib42]; [@bib44]; [@bib10]; [@bib29]; [@bib30]), it was of interest to compare the requirements for DC and B cell functions in these responses.

In addition to T cell recognition of peptide-MHCII (pMHCII) ligands shown to be critical in TD antibody responses ([@bib54]; [@bib55]; [@bib8]; [@bib19]; [@bib53]; [@bib10]), GC formation and function are dependent on CD80/CD86 ligands (B7.1/B7.2)--CD28 receptor and CD154 ligand (CD40L)--CD40 receptor interactions. Disruption of either of these co-stimulatory pathways results in severe defects in GC formation and antigen-specific class-switched antibody production ([@bib2]; [@bib28]; [@bib20]; [@bib13]; [@bib4]). Whereas CD28 and CD40L are expressed on T cells, B7 and CD40 are expressed on multiple cell types, including DCs and B cells. Thus, the requirement for B7--CD28 and CD40L--CD40 interactions could reflect requirements for both pathways in T--DC and T--B cell interactions, as presented in currently proposed models of the GC response ([@bib41]; [@bib57]; [@bib63]; [@bib9]; [@bib59]). It has in fact been posited that signaling interactions between B7 and CD40 expressed by the same B cell or DC are important for the function of these populations ([@bib27]; [@bib41]; [@bib63]; [@bib3]). Alternatively, these co-stimulatory pathways might have distinct roles restricted to either T--DC or T--B cell interactions, analogous to the SAP--SLAM pathway that is specifically required in stable T--B cell conjugation but dispensable for T--DC conjugation for GC responses ([@bib44]; [@bib5]). However, elucidation of the cellular and molecular interactions involved in the co-stimulatory signaling supporting GC responses, including Tfh cell and GC B cell development, has been limited, in part because of the lack of models for conditional expression of the critical B7 and CD40 molecules.

In the work reported here, we have identified spatially and temporally distinct patterns of T cell--APC interactions and have characterized the MHC dependency and co-stimulatory requirements for the primary GC response to vaccine challenge. We have generated conditional KOs (cKOs) for both B7 and CD40 and have used these, together with conditional MHCII KOs and BM chimeric strategies, to analyze the pathways involved in GC and antibody responses to antigen challenge. These experiments confirmed the expected requirement for MHCII-dependent interactions of T cells with both DCs and B cells in the generation of antigen-specific Tfh cells, antigen-specific GC B cells, and class-switched antibody responses to primary immunization with protein antigen and adjuvant. Our findings reveal, however, that the requirements for B7 and CD40 expression on DCs and B cells are distinct. B7 expression is needed on DCs but not on B cells, whereas cell-autonomous expression of CD40 is critical on B cells but not DCs, and there is in fact no requirement for coexpression of B7 and CD40 on the same cell in primary GC responses after vaccination. We have thus identified crucial and distinct contributions from two co-stimulatory pathways operating during T cell--APC interactions in the GC response.

Results {#s02}
=======

MHCII expression on both B cells and DCs is essential for primary GC responses {#s03}
------------------------------------------------------------------------------

Given the evidence for interactions of T cells with DCs and B cells during the GC response ([@bib42]; [@bib44]; [@bib10]; [@bib29]; [@bib30]), we examined the location and association of antigen-specific T cells with both of these APCs using histocytometry, a powerful quantitative imaging technique ([@bib15], [@bib16]; [@bib35]; [@bib46]). At multiple time points after OVA-specific OT-II T cell transfer and 4-hydroxy-3-nitrophenylacetyl (NP)--OVA/Alum immunization, histological sections of spleens and LNs were stained with antibodies specific for OT-II T cells, CD4^+^ T cells, B cells, DCs, and the Tfh cell/GC B cell marker Bcl6 (Fig. S1). We quantified T cell localization and T--APC interactions in the spleen and LN. At day 2, after immunization, antigen-specific OT-II T cells were found predominantly in T cell zones; by day 4, a significant proportion of OT-II T cells were also present in B cell follicles; and by days 7--8, the number of OT-II T cells in B cell follicles and GCs had increased (Fig. S1, A, C, and E). Intimate contacts between T cells and DCs were observed at relatively early time points in the GC response, whereas T--B cell interactions were maximal at later time points (Fig. S1, B and F).

We further assessed the requirements for these T--APC interactions in GC responses by analyzing requirements for MHCII expression in DCs or B cells. MHCII deletion from DCs, achieved by crossing MHCII (I-A^b^)^flox/flox^ and CD11c-Cre transgenic (Tg) mice, resulted in an absence of antigen-specific GC B cell development and IgG1 production ([Fig. 1, A and B](#fig1){ref-type="fig"}; and Fig. S2 A). We also assessed the cell type--specific requirement for MHCII in the generation of CXCR5^high^ PD-1^high^ GC Tfh cells ([@bib21]; [@bib6]; [@bib43]; [@bib56]) by transfer of OVA-specific OT-II T cells to recipient mice lacking MHCII on either DCs or B cells (Fig. S2 B). MHCII on DCs in recipient mice was critical for antigen-specific GC Tfh cell development as well as clonal expansion ([Fig. 1, C and D](#fig1){ref-type="fig"}; and Fig. S2 C). Deletion of MHCII on B cells in MHCII (I-A^b^)^flox/flox^ mice by crossing to CD19-Cre mice was previously reported to leave a residual small number of MHCII^+^ B cells that escape MHCII deletion and selectively expand to generate GC B cells ([@bib53]). We therefore used an alternative approach to analyze the role of MHCII on B cells for the GC response. Mixed BM chimeras that were reconstituted with MHCII WT BM + MHCII KO BM (Fig. S2 D) generated antigen-specific GC B cells and anti--NP IgG1 antibody derived exclusively from WT donors, demonstrating a cell-autonomous requirement for MHCII on B cells in these responses ([Fig. 1, E and F](#fig1){ref-type="fig"}). BM chimeras were also constructed by a mixture of B cell KO (μ mutation \[µMT\]) + MHCII KO BM (Fig. S2 E), resulting in a selective absence of MHCII on all B cells (MHCII^−/−^ + µMT). Antigen-specific GC Tfh cell development was essentially absent after OT-II T cell transfer to these chimeras despite intact expansion of overall OT-II numbers ([Fig. 1, G and H](#fig1){ref-type="fig"}). Together with the histocytometry findings depicted, these results demonstrated that MHCII-dependent T--DC and T--B cell interactions are spatially and temporally regulated and essential for the GC response.

![**Nonredundant requirements for MHCII on DCs and B cells in GC response.** (A) DC-specific MHCII cKO (MHCII^flox/flox^ × CD11c-Cre, termed DC-MHCII cKO) mice were immunized with NP­-KLH/Alum. At day 7 after immunization, NP-specific GC B cell numbers were analyzed in the spleen. Each strain, *n* = 3. Data are representative of three independent experiments. (B) DC-MHCII cKO mice were immunized with NP-KLH/Alum. 3 wk after immunization, anti-NP IgG1 titers were analyzed by ELISA. Dashed line indicates background OD value in empty wells. MHCII^flox/flox^, *n* = 4; DC-MHCII cKO, *n* = 4; and MHCII KO, *n* = 2. Data are representative of two independent experiments. (C and D) OT-II T cells (CD45.1) were transferred to the indicated recipient mice (CD45.2) followed by NP-OVA/Alum immunization, and transferred OT-II cells were analyzed at day 7. (C) Recovered total OT-II cell number (top), frequency of Tfh cells among OT-II (middle), and total OT-II Tfh cell number (bottom) from the spleen are shown. (D) Representative flow cytometry profile of splenic OT-II cells (CD4^+^ B220^−^ CD45.1^+^ Vα2^+^) analyzed for the Tfh CXCR5^high^ PD-1^high^ phenotype. Unimmunized, *n* = 4; MHCII^flox/flox^, *n* = 5; and DC-MHCII cKO, *n* = 6. Data shown are the combined result of two independent experiments. (E) Cell-intrinsic requirement of MHCII on B cells for antigen-specific GC development. MHCII WT (CD45.1) + MHCII KO (CD45.2) mixed BM chimeric mice and control MHCII WT (CD45.1) + MHCII WT (CD45.2) BM chimeric mice were prepared and immunized with NP-KLH. At day 7 after immunization, chimerism of total B cells (B220^+^; left) and NP-binding GC B cells from the spleen (B220^+^ GL7^+^ Fas^+^; right) was analyzed. Each group, *n* = 4. Data are representative of two independent experiments. (F) Cell-intrinsic requirement of MHCII on B cells for antigen-specific IgG1 production. MHCII WT (*Igh*^a^) and MHCII KO (*Igh*^b^) mixed BM chimera mice and control MHCII WT (*Igh*^a^) and MHCII WT (*Igh*^b^) BM chimera mice were prepared and immunized with NP-KLH/Alum. At 3 wk after immunization, anti--NP-IgG1 titers were analyzed by ELISA. Each group, *n* = 3. Data are representative of two independent experiments. (G and H) BM chimeras were reconstituted by a mixture of B cell KO (μMT) + MHCII KO BM (MHCII^−/−^+ μMT; Fig. S2 E), resulting in the selective absence of MHCII on all B cells. Control chimeras were reconstituted by a mixture of B cell KO (μMT) + MHCII WT BM (MHCII^+/+^ + µMT) BM. OT-II T cells (CD45.1) were transferred to recipient BM chimera mice (CD45.2) followed by NP-OVA/Alum immunization 1 d later, and splenic OT-II cells were analyzed at day 8 after immunization. (G) Recovered total OT-II cell number (top), frequencies of OT-II Tfh cells (middle), and number of total OT-II Tfh cells were analyzed (bottom). ns, not significant. (H) Representative flow cytometry plot of OT-II cells (CD4^+^ B220^−^ CD45.1^+^ Vα2^+^) analyzed for the Tfh CXCR5^high^ PD-1^high^ phenotype. Data presented are the combined result of three independent experiments. The total numbers of mice in the three combined experiments are unimmunized, *n* = 4; (MHCII^+/+^ + µMT) BM chimera, *n* = 3; and (MHCII^−/−^ + μMT) BM chimera, *n* = 5. Statistical significance was evaluated by Student's *t* test. All error bars represent mean ± SEM.](JEM_20161955_Fig1){#fig1}

Generation of B7 cKO mice {#s04}
-------------------------

In addition to requirements for MHCII recognition in GC responses, the absence of either B7--CD28 or CD40L--CD40 co-stimulatory interactions resulted in profound defects in GC formation and antigen-specific class-switched antibody response to TD antigen immunization ([@bib8]; [@bib19]; [@bib28]; [@bib20]; [@bib4]). Before immunization, B7.1 and B7.2 were expressed at substantially higher levels on DCs than on B cells. After immunization, B7.1 and B7.2 up-regulation was observed on GC B cells compared with non-GC follicular B cells (Fig. S3 A). In contrast, CD40 expression was slightly higher on B cells than on DCs throughout the course of GC response (Fig. S3 A). Because MHCII-dependent T cell interactions with both DCs and B cells were required for antigen-specific Tfh cell, GC B cell, and IgG1 responses, it was of interest to determine the requirements for co-stimulatory interactions of T cells with both DCs and B cells. The analysis of cell-specific CD28 co-stimulation by members of the B7 family has been constrained by the absence of models for conditional expression of the B7 ligands. Generation of conditional B7-deficient mice is made difficult by the fact that B7.1 (CD80) and B7.2 (CD86) are, to a substantial degree, functionally redundant and are encoded by closely linked genes ([@bib4]). To enable characterization of cell type--specific roles of B7, we generated B7 cKO mice by engineering a B7.1^flox^ BAC Tg and breeding this Tg to an endogenous B7.1 and B7.2 double KO (B7.1^−/−^and B7.2^−/−^; referred to as B7 DKO) background. These mice (B7.1^flox^ BAC Tg and B7 DKO) do not express endogenous B7.1 or B7.2 and therefore express only the B7.1^flox^ BAC Tg ([Fig. 2 A](#fig2){ref-type="fig"}). We refer to these mice hereafter as B7.1^flox^. B7.1 expression by the B7.1^flox^ BAC Tg, both ex vivo and after in vitro stimulation, showed expression patterns similar to that of endogenous B7.1 on DCs and B cells ([Fig. 2 A](#fig2){ref-type="fig"}), as well as on other cell types, including macrophages and thymic epithelial cells (Fig. S3 B). Consistent with the reported redundant roles of B7.1 and B7.2 in antibody responses to protein and adjuvant immunization ([@bib4]), reconstitution of B7 DKO mice with the B7.1^flox^ BAC Tg resulted in IgG1 and IgG2a antibody responses to TNP-KLH immunization comparable with those of WT B6 mice (Fig. S3 C). The B7.1^flox^ mouse was crossed to CD11c-Cre-- and CD19-Cre--expressing strains (all on a B7 DKO background) to generate DC-specific (DC-B7 cKO) and B cell--specific (BC-B7 cKO) B7 KO mice, respectively. In DC-B7 cKO mice, B7.1 was completely deleted from DCs with partial but substantially less B7.1 deletion from B cells, whereas in BC-B7 cKO mice, B7.1 expression was deleted from B cells but not DCs ([Fig. 2 B](#fig2){ref-type="fig"}). These conditional B7 KO mice thus enable analysis of cell type--specific B7 function.

![**B7 on DCs but not B cells is critical for TD antigen--specific IgG1 production.** (A) Generation of B7.1^flox^ mice. LoxP sites were inserted to flox exon 2 of the *B7.1* gene on the BAC. B7.1^flox^ BAC Tg mice were backcrossed to B7.1^−/−^ B7.2^−/−^ DKO mice to eliminate endogenous B7.1 and B7.2 expression. B7.1^flox^ Tg-B7 DKO mice expressed B7.1 on splenic DCs at a level similar to that of WT B6 mice before and after LPS stimulation in vitro. Data are representative of at least three independent experiments. (B) B7.1 expression on DCs and B cells of DC-specific and B cell--specific B7 cKO mice. Splenocytes were stimulated with ConA/LPS/IL-2 for 24 h, and B7.1 expression on DCs (CD11c^high^) and B cells (B220^+^) was analyzed. Shaded histograms indicate anti-B7.1 antibody staining of B7 cKO strains, and dashed lines indicate anti-B7.1 staining of B7.1/B7.2 DKO mice. Numbers indicate percentages of B7.1^+^ cells. Data are representative of three independent experiments. (C) Antigen-specific IgG1 production by B7 cKO strains. B7 cKO mice were immunized with NP-KLH/Alum. At 3 wk after immunization, serum anti-NP IgG1 titer was analyzed by ELISA. Dashed line indicates background OD value in empty wells. Each strain, *n* = 3. Data are representative of three independent experiments. ns, not significant. (D) Antibody affinity maturation was determined by ratio of high-affinity NP-specific IgG1 (measured by binding to NP~4~-BSA) to total NP-specific IgG1 (measured by binding to NP~25~-BSA) in serum at 7, 21, and 63 d after immunization. B7.1^flox^, *n* = 5; BC-B7cKO, *n* = 6 for day 7 and day 21 and *n* = 3 at day 63. Data are representative of three independent experiments. (E) NP-specific GC B cell development in B7 cKO strains. B7 cKO strains were immunized with NP-KLH/Alum. 1 wk after immunization, NP-binding GC B cells (B220^+^ GL7^+^ Fas^+^ NP-PE^+^) in the spleen were determined by flow cytometry. Data presented are the combined result of three independent experiments. The total numbers of mice in the three combined experiments are B7.1^flox^, *n* = 8; B7 DKO, *n* = 8; DC-B7 cKO, *n* = 6; and BC-B7 cKO, *n* = 8. (F) 1 wk after NP-KLH/Alum immunization, B7.1 expression on GC B cells was analyzed. Shaded histograms indicate anti-B7.1 staining, and dashed lines indicate isotype control staining. Data are representative of three independent experiments. (G) NP-specific GC B cell development in B cell--specific B7-deficient BM chimeras. BM chimeras were made that were completely and specifically deficient in expression of B7 on B cells by reconstitution of B cell KO hosts with a mixture of B7 DKO BM and B cell KO (μMT) BM (B7.1^−/−^ B7.2^−/−^ + μMT). Control chimeras were reconstituted with a mixture of B7 WT BM and B cell KO (μMT) BM (B7.1^+/+^ B7.2^+/+^ + μMT). Chimeras were immunized with NP-KLH/Alum. 1 wk after immunization, NP-binding GC B cells (B220^+^ GL7^+^ CD38^dull^ NP-PE^+^ IgG1^+^) in the spleen were determined by flow cytometry. Each group, *n* = 3. Data are representative of two independent experiments. Statistical significance was determined by Student's *t* test for single comparison or one-way ANOVA followed by Dunnett's method for multiple comparisons. All error bars represent the mean ± SEM.](JEM_20161955_Fig2){#fig2}

B7 expression on DCs but not B cells is critical for an antigen-specific GC B cell response and IgG1 production {#s05}
---------------------------------------------------------------------------------------------------------------

To analyze cell type--specific requirements for B7 expression in GC and IgG1 responses, mice with selective deletion of B7 in B cells or DCs were immunized with NP-KLH/Alum and antigen-specific GC B cells, and IgG1 production was evaluated. NP-specific IgG1 production was strongly dependent on B7 as indicated by the lack of IgG1 production in B7 DKO mice ([Fig. 2 C](#fig2){ref-type="fig"}). In the absence of Cre, B7.1^flox^ mice responded with robust IgG1 production ([Fig. 2 C](#fig2){ref-type="fig"}). Interestingly, IgG1 production was nearly absent in DC-B7 cKO mice ([Fig. 2 C](#fig2){ref-type="fig"}), demonstrating a strict requirement for B7 expressed on DCs in this response. In contrast, NP-specific IgG1 levels measured 21 and 63 d after immunization were undiminished in BC-B7 cKO mice ([Fig. 2 C](#fig2){ref-type="fig"} and Fig. S3 D), indicating that B7 expression on B cells was not required for this response. Notably, affinity maturation of NP-specific IgG1, regarded as an outcome of iterative Tfh--B cell interaction during the GC response, was equivalent in BC-B7 cKO and B7.1^flox^ mice through 63 d after immunization ([Fig. 2 D](#fig2){ref-type="fig"}). CD11c-Cre or CD19-Cre had no effect on NP-specific IgG1 production in the absence of floxed B7, excluding off-target effects of Cre expression (Fig. S3 E). We also analyzed the requirement for B7 expression in the generation of antigen-specific GC B cells. Consistent with the observed effects on serum IgG1 responses, NP-specific GC B cell development was decreased in DC-B7 cKO mice to the level seen in the complete absence of B7 (B7 DKO), whereas the response of BC-B7 cKO mice was not diminished from that seen in Cre-negative mice ([Fig. 2 E](#fig2){ref-type="fig"}). The NP-specific GC B cell response of BC-B7 cKO mice was similarly undiminished at low-dose antigen (10 µg NP-KLH/Alum) immunization conditions (Fig. S3 F). Light zone and dark zone GC B cell composition ([@bib58]) was also similar between BC-B7 cKO and undeleted control mice (Fig. S3 G). The antibody response observed in the BC-B7 cKO mice was not mediated by escapee B7.1^+^ B cells that had failed to undergo Cre-mediated deletion because B7.1 was not detected on GC B cells of the BC-B7 cKO mice ([Fig. 2 F](#fig2){ref-type="fig"}). As shown in [Fig. 2 A](#fig2){ref-type="fig"}, the B7 cKO BAC Tg mice generated in these experiments were constructed by introducing a floxed B7.1 BAC Tg to an endogenous B7.1 and B7.2 DKO background. Comparison of Cre-positive and Cre-negative cKO mice thus assessed the functional requirement for B7.1 in the absence of B7.2. To further test the requirement for B7 on B cells for GC B cell development, BM chimeras were made that expressed endogenous B7.1 and B7.2 on all cell types or that were completely deficient in the expression of both B7.1 and B7.2 only on B cells. B cell KO hosts were reconstituted with a mixture of B7 (B7.1 and B7.2) WT BM and B cell KO (µMT) BM (B7.1^+/+^ B7.2^+/+^ + µMT) or with a mixture of B7 DKO BM and B cell KO (µMT) BM (B7.1^−/−^ B7.2^−/−^ + µMT; Fig. S3 H). The BM chimeras in which all B cells were B7 DKO (B7.1^−/−^ B7.2^−/−^ + µMT) gave numbers of NP-specific IgG1^+^ GC B cells comparable with those in control mixed BM chimeras (B7.1^+/+^ B7.2^+/+^ + µMT), in which all B cells expressed both B7.1 and B7.2 ([Fig. 2 G](#fig2){ref-type="fig"}). These results demonstrate that B7 expression by DCs, but not B cells, is critical for an antigen-specific GC B cell response and high-affinity IgG1 production.

B7 expression by DCs, but not B cells, is important for antigen-specific T cell proliferation and Tfh cell development {#s06}
----------------------------------------------------------------------------------------------------------------------

To assess the B7 dependence of antigen-specific T cell activation and Tfh cell development, OT-II T cells (CD45.1) were transferred to control and B7 cKO mice (CD45.2), and the recipient mice were immunized with NP-OVA/Alum. To analyze the expansion of antigen-specific T cells, OT-II T cells were labeled with CFSE, and dye dilution was assayed at day 10 after NP-OVA/Alum immunization. The transferred OT-II cells underwent robust antigen-dependent cell division and expansion in the B7.1^flox^ and BC-B7 cKO host mice ([Fig. 3, A and B](#fig3){ref-type="fig"}). In contrast, OT-II T cell expansion did not occur in B7 DKO or DC-B7 cKO host mice ([Fig. 3, A and B](#fig3){ref-type="fig"}). We next assessed the generation of CXCR5^high^ PD-1^high^ GC Tfh cells within the OT-II population. GC Tfh cells were similar in number in B7.1^flox^ and BC-B7 cKOs but were severely reduced in B7 DKO and DC-B7 cKO recipient mice ([Fig. 3, C--E](#fig3){ref-type="fig"}). These results indicated that B7 expression by DCs was critical for antigen-specific CD4^+^ T cell expansion and GC Tfh cell development, but B7 on B cells was dispensable for these T cell responses.

![**Antigen-specific T cell activation and Tfh cell development require B7 on DCs but not B cells.** (A) B7 cKO strains (CD45.2) were adoptively transferred with CFSE-labeled OT-II T cells (CD45.1) and immunized with NP-OVA/Alum 1 d later. Spleens were harvested on day 10, and CFSE dilution was analyzed by flow cytometry. Dashed-line and shaded histograms indicate transferred OT-II T cells in unimmunized and immunized mice, respectively. Data are representative of three independent experiments. (B--E) OT-II cell transfer was done as described in A but without CFSE staining. Recovered total OT-II cell number (B), FACS analysis of Tfh (CXCR5^high^ PD-1^high^) OT-II cells (C), frequency of Tfh cells among OT-II (D), and total OT-II Tfh cell number were analyzed at days 8--10 after immunization (E). Data presented are the combined result of four independent experiments (mean ± SEM). The total numbers of mice in the four combined experiments are B7.1^flox^, *n* = 8; B7 DKO, *n* = 9; DC-B7 cKO, *n* = 8; and BC-B7 cKO, *n* = 11. Statistical significance was determined by one-way ANOVA followed by Dunnett's multiple comparison.](JEM_20161955_Fig3){#fig3}

Generation of CD40 cKO mice {#s07}
---------------------------

We next examined the cell type--specific requirements for CD40 in GC responses. We and others have previously reported that CD40 on B cells is required for TD antibody responses and GC formation, using BM chimera strategies ([@bib31]; [@bib36]), but the absence of conditional CD40-deficient mice prevented evaluation of CD40 function on other cell types, such as DCs, which express CD40 during the course of GC response (Fig. S3 A) or in nonchimeric experimental systems. We therefore generated CD40 cKO mice using a strategy similar to that described in [Fig. 2 A](#fig2){ref-type="fig"} for B7 cKO mice ([Fig. 4 A](#fig4){ref-type="fig"}). In CD40^flox^ BAC Tg mice, CD40 expression was derived from only the CD40^flox^ BAC Tg because the CD40 KO background of these mice eliminated expression of endogenous *CD40*. We refer to these mice (CD40^flox^ BAC Tg and CD40^−/−^) as CD40^flox^ mice hereafter. CD40 expression levels on activated B cells and DCs in CD40^flox^ mice were equivalent to those in heterozygous CD40^+/−^ mice expressing a single copy of the endogenous *CD40* gene ([Fig. 4 A](#fig4){ref-type="fig"}). CD40^flox^ mice were crossed to CD11c-Cre Tg mice (on an endogenous CD40 KO background) to generate DC-specific CD40 cKO (DC-CD40 cKO) mice. In these mice, CD40 cell surface expression was deleted specifically on DCs but not B cells ([Fig. 4 B](#fig4){ref-type="fig"}).

![**CD40 on B cells but not DCs is required for TD antigen--specific IgG production.** (A) Generation of CD40^flox^ mice. Exons 2 and 3 of the *CD40* gene on BAC were floxed by loxP sites (top). CD40^flox^ BAC Tg mice were backcrossed to CD40 KO mice to eliminate endogenous CD40 expression. CD40^flox^ BAC Tg expression on LPS-stimulated DCs and B cells is shown. (B) CD40 expression on LPS-stimulated splenic DCs and B cells of CD40^flox^, CD40^flox^ × CD11c-Cre Tg (DC-CD40 cKO), and CD40 KO mice. Splenocytes were stimulated with LPS for 48 h, and CD40 expression on B cells (B220^+^) and DCs (CD11c^+^) was analyzed by flow cytometry. Filled histograms show anti-CD40 antibody staining of CD40^flox^ or DC-CD40 cKO DCs and B cells. Dashed lines show anti-CD40 antibody staining of CD40 KO. (A and B) Data are representative of four independent experiments. (C) Antigen-specific IgG1 production of DC-CD40 cKO mice. Mice were immunized with NP-KLH/Alum, and serum was collected after 3 wk. Serum titer of anti-NP IgG1 was determined by ELISA. Dashed line indicates background OD value in empty wells. Data are combined results of four independent experiments. The total numbers of mice in the four combined experiments are CD40^flox^, *n* = 8; CD40 KO, *n* = 7; and DC-CD40 cKO, *n* = 6. ns, not significant. (D) Antibody affinity maturation was determined by the ratio of high-affinity NP-specific IgG1 to total NP-specific IgG1 in serum at 7 and 21 d after immunization. The total numbers of mice in the three combined experiments are CD40^flox^, *n* = 8; and DC-CD40 cKO, *n* = 6. (E) Mice were immunized with NP-KLH/Alum. At day 8 after immunization, the absolute number of NP-specific GC B cells (B220^+^ GL7^+^ CD38^dull^ NP-PE^+^) in the spleen was determined by flow cytometry. (D and E) Data presented are the combined result of three independent experiments. The total numbers of mice in the three combined experiments are CD40^flox^, *n* = 4; CD40 KO, *n* = 4; DC-CD40 cKO, *n* = 5; and unimmunized, *n* = 3. (F) Ex vivo IFN-γ production of purified splenic CD4^+^ T cells after stimulation with PMA and ionomycin for 2 h. Representative FACS plots are shown. The graph is a combined result of three independent experiments. The total numbers of mice in the three combined experiments are *n* = 3 for each strain. (G) WT (CD45.1) + CD40 KO (CD45.2) mixed BM chimera mice were immunized with NP-KLH/Alum, and NP-specific GC B cells were analyzed 1 wk later. Each group, *n* = 4. Data are representative of two independent experiments. Statistical significance was determined by Student's *t* test. All error bars represent means ± SEM.](JEM_20161955_Fig4){#fig4}

CD40 on B cells, but not on DCs, is required for an antigen-specific GC B cell response and IgG1 production {#s08}
-----------------------------------------------------------------------------------------------------------

To analyze DC-specific roles of CD40 for IgG1 responses and GC B cell induction, mice were immunized with NP-KLH/Alum. Equivalent NP-specific IgG1 production was observed in CD40^flox^ and DC-CD40 cKO mice, whereas this response was completely abrogated in CD40 KO mice ([Fig. 4 C](#fig4){ref-type="fig"}). NP-specific IgG1 produced in DC-CD40 cKO mice showed similar affinity maturation to that in CD40^flox^ mice ([Fig. 4 D](#fig4){ref-type="fig"}). Likewise, NP-specific GC B cell numbers were not significantly different between DC-CD40 cKO and CD40^flox^ mice, whereas NP-specific GC B cells were essentially absent in CD40 KO mice ([Fig. 4 E](#fig4){ref-type="fig"}). Composition of light zone/dark zone GC B cells ([@bib58]) was also similar between DC-CD40 cKO and CD40^flox^ mice (Fig. S4 A). These results indicate that CD40 expression on DCs is not required for efficient GC B cell and antibody responses. To confirm the functional deletion of CD40 on DCs, we examined the in vivo induction of IFN-γ--producing Th1 CD4^+^ T cells, previously shown to be a sensitive measure of CD40-dependent DC function ([@bib52]; [@bib14]). We observed that IFN-γ--producing CD4^+^ T cells were decreased in DC-CD40 cKO mice to a level similar to that of CD40 KO mice ([Fig. 4 F](#fig4){ref-type="fig"}), confirming the effectiveness of CD40 deletion from DCs.

We similarly tested the requirement for CD40 on B cells by generating B cell--specific CD40-deficient (BC-CD40 cKO) mice through crosses of CD40^flox^ to the CD19-Cre strain. BC-CD40 cKO mice generated NP-specific IgG1 and NP-binding GC B responses similar to those of Cre-negative CD40^flox^ mice (Fig. S4, B and C). This response was mediated by expansion of an initially small population of CD40^+^ escapee B cells that had failed to undergo Cre-mediated deletion and had selectively expanded and differentiated to GC B cells in BC-CD40 cKO mice (Fig. S4, C and D). This strong selective pressure suggested a critical role for CD40 on B cells in GC B cell development. The cell-intrinsic role of CD40 on B cells for antigen-specific GC B development was further analyzed using a mixed BM chimera strategy (Fig. S4 E). CD40 WT + CD40 KO mixed chimeras had similar proportions of peripheral B cells derived from CD40 WT and CD40 KO BM ([Fig. 4 G](#fig4){ref-type="fig"}, left). In contrast, antigen-specific GC B cells were essentially all of CD40 WT origin ([Fig. 4 G](#fig4){ref-type="fig"}, right). Together, these results demonstrate that CD40 expression on B cells is critical for GC B development and IgG1 production, whereas CD40 expression by DCs is not required for these same responses.

The role of CD40 on DCs and B cells for antigen-specific T cell proliferation and Tfh cell development {#s09}
------------------------------------------------------------------------------------------------------

To determine the cell type--specific role of CD40 for in vivo antigen-dependent T cell proliferation and Tfh cell differentiation, OT-II T cells (CD45.1) were transferred to recipients (CD45.2), which differed in their expression of CD40, followed by NP-OVA/Alum immunization. A week after immunization, there was no significant difference in the number of recovered OT-II cells in CD40^flox^, CD40 KO, and DC-CD40 cKO mice, indicating the absence of a requirement for CD40 in overall OT-II T cell expansion in response to antigen ([Fig. 5 A](#fig5){ref-type="fig"} and Fig. S4 F). In marked contrast, the percentage of GC Tfh cells among OT-II cells ([Fig. 5, B and C](#fig5){ref-type="fig"}) and the absolute number of the OT-II GC Tfh cells were drastically decreased in CD40 KO mice ([Fig. 5 D](#fig5){ref-type="fig"}), whereas those in DC-CD40 cKO were significantly greater than those in CD40 KO mice and intermediate between the numbers in CD40^flox^ and CD40 KO mice ([Fig. 5, B--D](#fig5){ref-type="fig"}). These results indicate that other non-DC CD40--expressing APCs are critical for inducing and maintaining a GC Tfh cell population that can support GC B cell responses and antigen-specific IgG1 production ([Fig. 4, C--E](#fig4){ref-type="fig"}). Because CD40^+^ escapee B cells in BC-CD40 cKO mice expanded to mediate normal GC B cell development and IgG1 production (Fig. S4, B--D), we were unable to test the contribution of CD40 signaling in B cells for Tfh cell development with this experimental design (Fig. S4, G--I). We therefore used an alternative approach to generate chimeric mice in which CD40 was selectively absent on all B cells and in which the role of CD40 on B cells could be tested in the generation of Tfh cells. A mixture of BM from B cell KO (μMT) and CD40 KO donors was used to reconstitute irradiated B cell KO host mice, generating chimeras (CD40^−/−^ + μMT) in which all B cells were constitutively CD40 deficient (Fig. S4 J). OT-II T cells were transferred to these chimeric mice, and Tfh cell development was evaluated after NP-OVA/Alum immunization. Transferred OT-II cells expanded to an equivalent extent in the presence or absence of CD40 expression on B cells ([Fig. 5 E](#fig5){ref-type="fig"}). In contrast, GC Tfh cell phenotype OT-II cells were observed only in control chimeras (CD40^+/+^ + μMT) containing CD40-expressing B cells, but not in B cell--specific CD40 KO (CD40^−/−^ + µMT) chimeras ([Fig. 5, F--H](#fig5){ref-type="fig"}), indicating that CD40 on B cells was critical for Tfh cell development.

![**Antigen-specific T cell activation and Tfh cell development require CD40 on B cells but not DCs.** (A--D) Naive OT-II CD4^+^ T cells were transferred to CD40 cKO mice followed by NP-OVA/Alum immunization 1 d later, and splenic OT-II cells were analyzed at day 8 after immunization. Recovered total OT-II cell number (A), FACS plot of OT-II (CD4^+^ B220^−^ CD45.1^+^ Vα2^+^) cells analyzed for Tfh CXCR5^high^ PD-1^high^ phenotype (B), frequency of Tfh cells among OT-II (C), and total OT-II Tfh cell number were determined (D). Data are combined from three independent experiments. The total numbers of mice in the three combined experiments are CD40^flox^, *n* = 8; CD40 KO, *n* = 8; and DC-CD40 cKO, *n* = 11. ns, not significant. (E--H) A mixture of BM from B cell KO and CD40 KO donors was used to reconstitute irradiated B cell KO host mice, generating chimeras in which all B cells were constitutively CD40 deficient (CD40^−/−^ + µMT). Control chimeras received a mixture of BM from B cell KO and WT donors (CD40^+/+^ + µMT). OT-II T cells were transferred to recipient BM chimera mice (CD45.2) followed by NP-OVA/Alum immunization 1 d later, and splenic OT-II cells were analyzed at day 8 after immunization. Recovered OT-II cell number (E), FACS plot of OT-II (CD4^+^ CD45.1^+^ Vα2^+^) cells analyzed for the Tfh CXCR5^high^PD-1^high^ phenotype (F), frequency of OT-II Tfh cells among total CD4^+^ T cells (G), and the number of Tfh phenotype OT-II cells were analyzed (H). Data presented are the combined result of three independent experiments. The total numbers of mice in the three combined experiments are unimmunized, *n* = 3; (CD40^+/+^ + µMT) BM chimera, *n* = 3; and (CD40^−/−^ + μMT) BM chimera, *n* = 5. Statistical significance was determined by Student's *t* test. All error bars represent means ± SEM.](JEM_20161955_Fig5){#fig5}

The demonstration of a cell-autonomous requirement for CD40 on B cells during GC B cell responses ([Fig. 4 G](#fig4){ref-type="fig"}) is consistent with previous demonstrations of direct signaling through CD40 on B cells ([@bib18]; [@bib45]). In contrast, it is not clear whether signaling through CD40L on T cells plays a functional role in T cell responses. We therefore tested whether there is a cell-autonomous requirement for CD40L expression on T cells for Tfh cell generation. A mixture of CD40L WT (CD45.1) and CD40L KO (CD45.1/CD45.2) OT-II cells was transferred to WT B6 (CD45.2) host mice and followed by NP-OVA/Alum immunization. CD40L WT and CD40L KO OT-II cells expanded equivalently and generated similar numbers of GC Tfh cells (Fig. S4, K--M). Therefore, cell-autonomous expression of CD40L on T cells is not necessary for T cell expansion and Tfh cell differentiation.

CD40 and B7 on distinct cell populations cooperate to support the GC response {#s10}
-----------------------------------------------------------------------------

Our results indicate that antigen-specific GC B cell responses require both B7 on DCs and CD40 on B cells, but neither CD40 on DCs nor B7 on B cells is necessary. To test directly whether GC responses could be induced in the absence of both CD40 on DCs and B7 on B cells, B7 DKO (B7.1^−/−^, B7.2^−/−^, CD40^+/+^) B cells were adoptively transferred to CD40 KO (B7.1^+/+^, B7.2^+/+^, CD40^−/−^) recipients, which were then immunized with NP-OVA/Alum. Under these experimental conditions, 8--10% of splenic B cells in the CD40 KO host were CD40^+^ and thus corresponded to adoptively transferred B7 DKO B cells, whereas 90% of B cells were of host origin ([Fig. 6 A](#fig6){ref-type="fig"}). DCs and other cell types in CD40 KO hosts were CD40 KO but B7 WT (B7.1^+/+^, B7.2^+/+^, CD40^−/−^). Strikingly, essentially all NP-specific IgG1^+^ class-switched GC B cells were detected in the donor CD40^+^ B7^−^ B cell compartment in CD40 KO recipient mice ([Fig. 6, A and B](#fig6){ref-type="fig"}). Of note, the ability of donor B7 DKO B cells (B7.1^−/−^, B7.2^−/−^, CD40^+/+^) to develop antigen-specific GC B cells in CD40 KO recipient mice was comparable with that of donor B7 WT B cells (B7.1^+/+^, B7.2^+/+^, CD40^+/+^), indicating that there is no requirement for B7.1 or B7.2 on B cells in this response (Fig. S5 A). In contrast, the reciprocal transfer of CD40 KO B cells (B7.1^+/+^, B7.2^+/+^, CD40^−/−^) into B7 DKO (B7.1^−/−^, B7.2^−/−^, CD40^+/+^) hosts failed to support a GC response to the same immunization ([Fig. 6 B](#fig6){ref-type="fig"}). These results demonstrate that neither CD40 on DCs nor B7.1/B7.2 on B cells is required for GC B cell responses. CD40^+^ B7^−^ B cells and a distinct population of B7^+^ CD40^−^ DCs were capable of efficient cooperation in GC responses, with no requirement for expression of both B7 and CD40 on the same cell ([Fig. 6](#fig6){ref-type="fig"} and Fig. S5).

![**GC responses are elicited by CD40 KO DCs and B7 KO B cells.** (A) B cells were purified from B7 DKO mice and adoptively transferred to CD40 KO mice. Host mice were immunized with NP-OVA/Alum 1 d after transfer. 8 d later, splenocytes were analyzed for antigen-specific GC B population. (B) Frequency of GC B cells, NP-binding GC B cells in each B cell compartment, and frequency of IgG1^+^ cells among NP-binding GC B cells were analyzed. Data presented are the combined result of three independent experiments (mean ± SEM). The total numbers of mice in the three combined experiments are WT, *n* = 7; CD40 KO, *n* = 6; B7 DKO B cells into CD40 KO mice, *n* = 8; and CD40 KO B cells into B7 DKO mice, *n* = 3. Statistical significance was determined by Student's *t* test.](JEM_20161955_Fig6){#fig6}

Discussion {#s11}
==========

T cell--dependent GC responses require coordinated interactions of T cells with antigen-presenting B cells and DCs. We used histocytometry to add to the existing data on the tissue localization of T cell--APC interactions during GC responses to primary vaccine immunization with protein antigen and adjuvant. Our experiments identified spatially and temporally distinct patterns of physical interactions of T cells with both populations of APCs. Although B7- and CD40-dependent co-stimulatory pathways, in addition to cognate MHCII--TCR interactions, are essential for GC responses ([@bib28]; [@bib20]; [@bib13]; [@bib4]), a comprehensive analysis of cell type--specific pathways has been hindered by the absence of models for conditional expression of B7 or CD40. We generated cKO models for both B7 and CD40 and used these genetic lines, together with conditional MHCII KOs and BM chimeric strategies, to analyze pathways involved in TD GC and antibody responses. Our results indicated that recognition of antigen presented by MHCII expressed by both DCs and B cells is necessary for the generation of antigen-specific Tfh cells, GC B cells, and antibody responses. Notably, the cellular requirements for B7 and CD40 expression were, in contrast, distinct: B7 expression on DCs was required for GC responses, but there was no requirement for B7 expression on B cells; reciprocally, CD40 was required on B cells but not DCs for the generation of antigen-specific Tfh cells, GC B cells, and sustained high-affinity class-switched antibody responses. These findings support a model in which, contrary to current paradigms, distinct cell populations engage in the major co-stimulatory interactions necessary for effective primary Tfh cell and GC responses. There is in fact neither a requirement for expression of B7 on B cells nor a requirement for expression of both B7 and CD40 on the same cell under conventional vaccination conditions (Fig. S5 B).

Tfh cell differentiation and GC formation have been described as a multistep process ([@bib57]; [@bib9]; [@bib59]). Initiation of Tfh cell differentiation has been suggested to begin with priming of a naive CD4^+^ T cell by antigen-presenting DCs. Subsequent signals determine Tfh cell differentiation fate in response to factors, including cytokines, most specifically IL-6, which induce Bcl6 and its downstream target events and chemokine-driven migration to the B cell follicle ([@bib9]; [@bib59]). Another cytokine, IL-2, has a negative role on Tfh cell development ([@bib6]; [@bib9]; [@bib59]). It was recently shown that DCs present in the outer T cell zone promote Tfh cell differentiation by quenching IL-2 availability in this distinct lymphoid niche ([@bib33]). Later stages of Tfh cell differentiation occur through interactions with antigen-specific B cells in the follicle, where the efficiency of antigen presentation to Tfh cells is critical in the selection of B cells ([@bib9]; [@bib59]). Those B cells that, as a consequence of activation-induced cytidine deanimase (AID)--dependent SHM, express progressively higher BCR affinity for antigen and therefore interact most effectively with Tfh cells via antigen presentation are selectively driven through cycles of proliferation and interzonal migration ([@bib57]). These later events in the GC response, which are reflected in affinity maturation of BCRs and antibody production, thus appear to depend heavily on Tfh cell interactions with GC B cells.

We explored the requirement for recognition of antigen presented by MHCII on B cells and DCs in primary GC responses using mixed BM chimeras as well as MHCII cKO mice. Consistent with previous studies ([@bib53]; [@bib10]), MHCII expression by B cells was important for GC B cell and antibody responses. We found no evidence of bystander B cell responses driven in a noncognate fashion by cytokines or CD40L from T cells activated by neighboring MHCII^+^ antigen-presenting B cells. In addition, we identified a requirement for MHCII expressed on DCs for GC B cell and antibody responses, indicating a nonredundant role for T cell--DC interactions, consistent with the proposed role of DCs in the initial antigen-specific stimulation of naive CD4^+^ T cells ([@bib24]). Although it has been reported that B cells are also capable of stimulating primary T cell responses ([@bib38]; [@bib7]; [@bib12]; [@bib47]), this may occur only under conditions in which B cells express BCRs with sufficient antigen affinity to mediate efficient presentation to T cells. These conditions may exist during later stages of the GC response and, in fact, appear to underlie the selection of B cells expressing high-affinity BCRs for specific antigen ([@bib57]).

Given the apparent requirement for cognate T cell interactions with both B cells and DCs during the course of a GC response, it was of interest to define cooperative co-stimulatory signaling events involved in productive T cell interactions with each of these populations. A requirement for CD28-B7 co-stimulation in GC and TD antibody responses had been established by studies of constitutive deficiency in these pathways, as well as by the effect of blocking antibodies in vivo ([@bib20]; [@bib4]). The experiments reported here used mice conditionally deficient for B7, allowing direct tests of the requirement for B7 on B cells or DCs. We found a strict requirement for B7 on DCs for antigen-specific TD antibody, Tfh cell, and GC B cell responses. Thus, MHCII-dependent activation of T cells by DCs for clonal expansion and subsequent differentiation to Tfh cells appears to require B7 co-stimulation, consistent with the reported co-stimulatory requirement for T cell functional activation ([@bib11]), in particular naive T cells, in a variety of settings. In contrast, there was no requirement for B7 expression by B cells in T cell clonal expansion or Tfh cell development despite the demonstrated requirement for recognition of pMHCII on B cells in Tfh cell generation. Notably, we also found that B7 expression on B cells was dispensable for WT levels of class-switched antibody responses and for affinity maturation, which has been shown to be dependent on iterative interactions between Tfh and GC B cells. These findings indicate that effective communication between T cells and pMHCII-bearing B cells leading to Tfh cell generation, GC B cell differentiation, and affinity maturation during antigen-specific GC responses does not require B7 co-stimulation. This result is consistent with our previous finding in WT + B7 DKO BM chimeras, which suggested that there is no requirement for cell-autonomous B7 expression on B cells for TD antibody responses but did not address the overall requirement for B7 expression on B cells because of the presence of B7 WT B cells in these chimeras and did not assess GC formation or the GC origin of these responses ([@bib36]). Recent publications have suggested that B cells have a cell-intrinsic requirement for expression of CD80 and/or CD86 for differentiation into GC B cells ([@bib51]; [@bib60]). Interestingly, the data that were presented in support of that suggestion did not measure the antigen specificity of the GC response being characterized. A recent B7-blocking study suggested B7's role in supporting the Tfh population after GC formation ([@bib34]), but it is not clear whether this resulted from B7 blockage at the T--DC or T--B cell interaction, and B7 at the DC--T cell interaction might still be required at a relatively later stage of GC response to support Tfh cell differentiation and functions ([@bib32]). Recent studies analyzing the role of T follicular regulatory cells (Tf reg cells) in GC responses proposed that Tf reg cells might function through CTLA-4--mediated down-regulation of B7 on B cells ([@bib50]; [@bib60]). However, our results indicate that there is no requirement for B7.1 or B7.2 on B cells for antigen-specific Tfh generation, GC B development, or high-affinity antibody production, and analysis of the mechanism mediating Tf reg cell function in antigen-specific GC responses will require further study ([@bib49]).

The requirement for CD28 co-stimulation in T cell activation has been shown to be critically dependent on the strength of primary TCR-mediated antigenic signaling, with strong TCR signaling associated with a decreased requirement for co-stimulation ([@bib1]). During the course of GC responses, the initial T cell response appears to be initiated by a DC as an APC. In this interaction, the relatively low efficiency of antigen presentation may be associated with the limited strength of TCR signaling and hence a strong requirement for B7-dependent co-stimulation by DCs. Later in the GC response, Tfh cells interact with GC B cells, which undergo SHM through iterative interaction with Tfh, resulting in increased BCR affinity for antigen and consequently enhanced efficiency of antigen presentation and strength of TCR signaling ([@bib57]). Under the conditions of primary GC responses that we have analyzed, efficient pMHCII presentation by B cells may obviate the requirement for B7 co-stimulation by B cells. The observed absence of B7 dependence may also reflect additional parameters of the activation or differentiation state of the Tfh cells that are interacting with B cells. Inducible T cell co-stimulator (ICOS) molecules induced on activated T cells by B7--CD28 co-stimulation ([@bib37]) were shown to be critical for Tfh cell development and the GC response ([@bib6]) through interaction with ICOS ligand on B cells ([@bib39]; [@bib61]), possibly supplanting the requirement for B7 co-stimulation in Tfh cells interacting with GC B cells. Also of interest is the recent study showing that PD-1 can function to suppress signaling through CD28 rather than through the TCR ([@bib22]; [@bib26]). Down-regulation of CD28 signaling in PD-1^high^ GC Tfh cells by PD-1 ligands on GC B cells may therefore obviate any role for co-stimulation through B7 on GC B cells. Our finding that B7 expression on B cells is not required for antigen-specific GC responses is based on a primary conventional protein/adjuvant vaccination model. It remains to be determined whether co-stimulatory requirements differ for other vaccine strategies or infection models.

GC B cell responses and TD antibody responses are strongly dependent on CD40, as initially demonstrated by the inhibitory effects of blocking anti-CD40 antibodies and studies of CD40-deficient mice ([@bib28]; [@bib20]). Use of CD40 cKO mice in addition to chimera strategies in this study has permitted analysis of the requirement for CD40 on B cells or DCs in the generation of Tfh cells and productive GC responses. Cell type--specific requirements for CD40 were in fact strikingly reciprocal to the requirement for B7. CD40 expression on B cells was required for GC and antibody responses, but these responses were not affected by deletion of CD40 from DCs. The requirement for CD40 expression on B cells was cell autonomous, as reflected in mixed BM chimeras. This suggests that CD40 functions by signaling through this molecule on B cells, consistent with previous in vitro and in vivo studies demonstrating a role of CD40 in signaling B cell proliferation and differentiation ([@bib23]; [@bib18]; [@bib36]). In contrast, our data from studies of cotransferred CD40L WT and CD40L KO T cells indicated that CD40L expression on a T cell is not cell autonomously required for expansion and Tfh cell differentiation of that T cell in this experimental setting. However, the overall requirement for CD40L signaling in Tfh generation is not clear because a role for CD40L signaling on the cotransferred CD40L WT T cells cannot be excluded.

Collectively, these findings support a model in which requirements for co-stimulatory signaling involving B7 and CD40 are segregated to distinct cells and components of the primary GC response (Fig. S5 B), providing a strong parallel to the differential adhesive molecular requirements for T--DC versus T--B cell interactions revealed in studies of SAP-deficient animals ([@bib44]; [@bib5]). Initial activation of CD4^+^ T cells is dependent on cognate interactions with antigen-presenting DCs. Generation of expanded T cell populations upon such antigen recognition requires co-stimulation of the T cells by B7 expressed by the DC, without an essential role of CD40. Subsequent generation of GC Tfh cells and the function of these Tfh cells in supporting GC B cell proliferation, differentiation, class switch recombination, SHM, and affinity maturation are all dependent on pMHC cognate interactions between Tfh cells and B cells and require CD40 but not B7 expressed on B cells.

Our results challenge previously proposed models for the interaction of B7--CD28 and CD40L--CD40 co-stimulatory pathways in the activation and differentiation of T cells. It has been suggested that CD40L on activated T cells signals through CD40 on APCs to up-regulate B7 on those APCs, providing positive feedback between B7--CD28 and CD40L--CD40 co-stimulatory pathways ([@bib48]; [@bib18]; [@bib45]). However, our findings indicate that there is in fact no requirement for the expression of both B7 and CD40 on the same cell in mediating efficient GC responses. Rather, each co-stimulatory pathway has distinct cell type--specific roles in these TD responses (Fig. S5 B).

These findings have implications for opportunities to modulate humoral immunity at each stage of the GC response through cell-specific targeting of distinct co-stimulatory pathways. Interfering with B7--CD28 co-stimulation should be effective in preventing antigen-specific CD4^+^ T cell clonal expansion and subsequent Tfh cell differentiation by acting at the initial stage of the response mediated by T cell--DC interactions. B7--CD28 blockade would be less effective at later stages of the GC response that are mediated by T--B cell interactions, where we show that B7 plays a negligible role. In contrast, interfering with the CD40 pathway should not impact CD4^+^ T cell clonal expansion mediated by T cell--DC interaction, but would be effective at inhibiting T--B cell interactions in developing and developed GC reactions at later stages.

Materials and methods {#s12}
=====================

Mice {#s13}
----

C57BL/6 and B6.CD45.1 mice were obtained from the National Institutes of Health. B7.1/B7.2 DKO (B7 DKO), CD40 KO, B cell KO (IgM KO, μMT), MHCII KO, MHCII(I-A^b^)^flox/flox^, *Igh*^a^ congenic, CD11c-Cre-Tg, CD11c-EGFP-Cre-Tg, CD19-Cre knock-in, and OT-II TCR Tg mice were purchased from Jackson Laboratory. BM chimera mice were generated by reconstitution of 10^7^ total T cell--depleted BM cells from donor mice to irradiated (950 rad) host mice i.v. Mice were maintained in accordance with National Institutes of Health guidelines. All animal experiments were approved by the National Cancer Institute and the National Institute of Allergy and Infectious Diseases Animal Care and Use Committees.

Immunofluorescence and confocal microscopy {#s14}
------------------------------------------

Draining LNs and spleens were harvested and fixed with PLP buffer (0.05 M phosphate buffer containing 0.1 M [l]{.smallcaps}-lysine, pH 7.4, 2 mg/ml NaIO~4~, and 10 mg/ml paraformaldehyde) for 12 h. After fixation, tissues were incubated in 30% sucrose for 6 h before embedding in optimum cutting temperature compound (Tissue-Tek). 30-μm sections were cut on a cryostat (CM3050S; Leica) and adhered to slides (Super Frost Plus Gold; Electron Microscopy Services). Frozen sections were permeabilized and blocked for 1--2 h in PBS containing 0.3% Triton X-100 (Sigma-Aldrich), 1% normal mouse serum, 1% BSA, and 10% normal goat serum. Sections were stained with directly conjugated antibodies for a minimum of 5 h at room temperature or 12 h at 4°C in a humidity chamber in the dark. Anti--mouse CD80, CD86, CD45.1, CD4, and B220 antibodies were purchased from BioLegends. Anti--mouse CD11c antibody was purchased from Thermo Fisher. Anti-Bcl6 antibody was purchased from BD Biosciences. Cell nuclei were visualized with JOJO-1 (Thermo Fisher). Stained slides were mounted with Fluoromount G (eBioscience) and sealed with a glass coverslip. Each section was visually inspected by epifluorescent light microscopy, and several representative sections from different lymphoid organs were acquired using a confocal microscope (SP8; Leica) and 40× objective (numerical aperture 1.3).

Histocytometry {#s15}
--------------

For histocytometric analysis of OT-II cells, we developed a seven-color panel consisting of the following fluorophores: brilliant violet 421, brilliant violet 510, Alexa Fluor 488, JOJO-1, Alexa Fluor 594, Alexa Fluor 647, and Alexa Fluor 700. Fluorophore emission was collected on separate detectors with sequential laser excitation used to minimize spectral spillover. The channel dye separation module within the LAS AF software (Leica) was then used to correct for any residual spillover. Representative tile scans were taken at a voxel density of 1,024 × 1,024 and 1-µm z step. Threshold identification, voxel gating, surface creation, masking, and signal segmentation were performed as previously described ([@bib15], [@bib16]; [@bib46]). Channel statistics for all surfaces were exported into Excel (Microsoft) and converted to a CSV file for direct visualization in FlowJo v10.1r5 (Tree Star). Mean voxel intensities for all channels were plotted on a linear scale and used for gating distinct leukocyte populations. Position data were also exported into FlowJo and used to gate B cell follicles, T cell zones, GCs, T--B cell borders, and white pulp regions in the spleen. To determine the phenotype of APCs in association with OT-II cells, CD11c and B220 fluorescence intensities were examined on OT-II cell surfaces (CD45.1^+^CD4^+^) as a surrogate for OT-II association with CD11c^+^ DCs or B220^+^ B cells as described previously for OT-I cells ([@bib16]; [@bib46]).

Generation of B7^flox^ and CD40^flox^ BAC Tg mice {#s16}
-------------------------------------------------

BAC DNA (RP23-206M14 for B7.1 and RP23-413G19 for CD40) was obtained from the BACPAC Resource Center (Children's Hospital Oakland Research Institute). Each loxP site was inserted by standard BAC recombineering methods (<https://ncifrederick.cancer.gov/research/brb/recombineeringinformation.aspx>). The engineered BAC DNA was linearized by NotI digestion and purified and injected into C57BL/6-fertilized eggs. Founder lines positive for BAC Tgs were backcrossed to constitutive B7 DKO or CD40 KO strains to generate B7.1^flox^ BAC Tg (endogenous B7.1 and B7.2 DKO) and CD40^flox^ BAC Tg (endogenous CD40 KO) mice.

Immunizations and adoptive transfer studies {#s17}
-------------------------------------------

Mice were immunized i.p. with 100 µg NP-KLH or NP-OVA (Biosearch Technologies) mixed with Imject Alum (Pierce). For adoptive transfer experiments, CD45.1 OT-II Tg CD4^+^ T cells were purified with a MACS CD4^+^ T cell isolation kit (Miltenyi Biotec), and 5 × 10^5^ cells were transferred i.v. to host mice 1 d before immunization. Splenic B cells were purified with MACS pan--B cell isolation kits (Miltenyi Biotec), and 3 × 10^7^ cells were transferred i.v. to host mice 1 d before immunization.

Flow cytometry {#s18}
--------------

Cells were washed with FACS buffer (HBSS containing 0.2% BSA and 0.05% Azide), treated with anti-FcR (24G2), and then stained with specific antibodies. Anti--mouse CD4, CD8, PD-1, CXCR5, B220, CD19, Fas, GL7, CD38, CD11c, B7.1, B7.2, CD40, CXCR4, CD83, TCR-Vα2, TCR-Vβ5, CD45.1, and CD45.2 antibodies were purchased from BD Biosciences. NP-PE was purchased from Biosearch Technologies. Propidium iodide was purchased from Sigma-Aldrich. For intracellular cytokine staining, splenic CD4^+^ T cells were stimulated with PMA and ionomycin for 2 h, and cells were fixed and permeabilized with the BD Fix/Perm kit (BD Biosciences) according to the manufacturer's instructions and then stained with anti--IFN-γ (BD Biosciences) and isotype control antibody for 30 min. Data were collected with a FACS Calibur II, FACS LSR II, FACS Fortessa, or FACS Aria III flow cytometer (BD Biosciences) and analyzed with FlowJo software.

ELISA {#s19}
-----

NP-specific IgG1 was measured by ELISA. In brief, NP~25~-BSA (Biosearch Technologies) was coated on ELISA plates (Immulon 4HBX; Thermo Fisher) overnight. The plates were then washed with ELISA wash buffer (0.5% Tween in PBS), serially diluted sera were applied to the plates, and plates were incubated 2 h at room temperature. Anti--mouse IgG1 HRP (Southern Biotech) was used to detect NP-specific IgG1. To measure IgG1 affinity maturation, antibody titer was determined with NP~4~-BSA and NP~25~-BSA. For allotype-specific IgG1 detection, anti--mouse IgG1^a^ or IgG1^b^-biotin antibody (BD Biosciences) was used and followed by a streptavidin-HRP (BD Biosciences) reaction. After a wash step, 2,2\'-Azino-di-(3-ethylbenzthiazoline-6-sulfonate) (ABTS) substrate (KPL) was added to the wells, and enzyme reaction was stopped by ABTS HRP Stop Solution (KPL). Optical density at 405 nm was measured with Fluostar Optima plate reader and software (BMG Labtech).

Statistical analysis {#s20}
--------------------

Student's *t* test with two-tailed distributions was performed for statistical analyses with single comparisons. For multiple comparisons, statistical analysis was performed with one-way ANOVA followed by Dunnett's multiple comparison. P-values \<0.05 were considered statistically significant.

Online supplemental material {#s21}
----------------------------

Fig. S1 is histocytometry analysis of GC response. Fig. S2 is supplemental data related to [Fig. 1](#fig1){ref-type="fig"}. Fig. S3 is supplemental data related to [Fig. 2](#fig2){ref-type="fig"}. Fig. S4 is supplemental data related to [Fig. 4](#fig4){ref-type="fig"} and [Fig. 5](#fig5){ref-type="fig"}. Fig. S5 is supplemental data related to [Fig. 6](#fig6){ref-type="fig"}.
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